Jojima T, Uchida K, Akimoto K, Tomotsune T, Yanagi K, Iijima T, et al
In addition, a meta-analysis of the HARMONY studies of albiglutide revealed that the risk of cardiovascular events was not significantly higher in subjects on albiglutide than in subjects on all other comparators including placebo and oral antidiabetic drugs such as glimepiride, insulin glargine, insulin lispro, liraglutide, pioglitazone, and sitagliptin [99]
Metabolism: Clinical and Experimental
[9] If you prefer a digital-first experience, Found is designed for convenience
No cost to apply 100% private 94.6% of members hit their goal If you don't hit your goal weight we pay for it.* Most GLP-1 providers can't afford to offer this